The final results verify conclusions drawn by Bagli et al. [1], who carried out a examine that involved 10 patients diagnosed with CRAO who gained HBOT. Besides getting 20 periods of HBOT, oral acetazolamide and topical beta-blockers were being administered for the patients on the earliest probable time.We only use top quality, credible sources to